跳至主要内容
临床试验/NCT05273411
NCT05273411已完成不适用

The Effect of Different Ketone Supplements on Blood Beta-hydroxybutyrate (β-OHB) and Blood Glucose in Healthy Individuals

University of British Columbia2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2022年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Blood Beta-hydroxybutyrate

研究概览

简要总结

Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • over the age of 18;
  • able to fast overnight

排除标准

  • being a competitive endurance athlete;
  • following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements;
  • being unable to travel to and from the university;
  • being unable to follow the diet instructions;
  • being pregnant or planning to become pregnant during the study;
  • having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease;
  • being unable to read or communicate in English

结局指标

主要结局

Blood Beta-hydroxybutyrate

时间窗: 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)

Are under the curve (AUC) across 240 minutes after supplement consumption (assessed at baseline and 15, 30, 60, 90, 120, 180, and 240 post-supplementation)

次要结局

  • Hunger & Fullness(240 minutes post-supplementation)
  • Blood Pressure(240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation))
  • Supplement Acceptability & Taste(240 minutes post-supplementation)
  • Gastrointestinal Discomfort(60 minutes post-supplementation)
  • Blood Glucose(240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation))
  • Heart Rate(240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Little

Dr. Jonathan Little, Associate Professor

University of British Columbia

研究点 (2)

Loading locations...

相似试验